These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7503194)

  • 21. Sulindac to prevent recurrent preterm labor: a randomized controlled trial.
    Humphrey RG; Bartfield MC; Carlan SJ; O'Brien WF; O'Leary TD; Triana T
    Obstet Gynecol; 2001 Oct; 98(4):555-62. PubMed ID: 11576567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations.
    Lam F; Bergauer NK; Jacques D; Coleman SK; Stanziano GJ
    J Perinatol; 2001; 21(7):444-50. PubMed ID: 11894512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome.
    Aggarwal A; Bagga R; Girish B; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Feb; 38(2):177-184. PubMed ID: 28784001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical efficacy of oral tocolytic therapy.
    Rust OA; Bofill JA; Arriola RM; Andrew ME; Morrison JC
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):838-42. PubMed ID: 8885732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump.
    Allbert JR; Johnson C; Roberts WE; Martin RW; Gookin KS; Morrison JC
    J Reprod Med; 1994 Aug; 39(8):614-8. PubMed ID: 7996525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of tocolytic use in the management of symptomatic placenta previa.
    Besinger RE; Moniak CW; Paskiewicz LS; Fisher SG; Tomich PG
    Am J Obstet Gynecol; 1995 Jun; 172(6):1770-5; discussion 1775-8. PubMed ID: 7778631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and economic outcomes of preterm labor management: inpatient vs outpatient.
    Ambrose S; Rhea DJ; Istwan NB; Collins A; Stanziano G
    J Perinatol; 2004 Aug; 24(8):515-9. PubMed ID: 15141268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal morbidity between 34 and 37 weeks' gestation.
    Fox MD; Allbert JR; McCaul JF; Martin RW; McLaughlin BN; Morrison JC
    J Perinatol; 1993; 13(5):349-53. PubMed ID: 8263618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of preterm birth: early detection and aggressive treatment with terbutaline.
    Adkins RT; Van Hooydonk JE; Bressman PL; Growdon JH; Bolen PR; Varin JC; Thompson BR
    South Med J; 1993 Feb; 86(2):157-64. PubMed ID: 8240475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic tocolysis of twins.
    O'Leary JA
    Am J Obstet Gynecol; 1986 Apr; 154(4):904-5. PubMed ID: 3963080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the subcutaneous terbutaline pump for long-term tocolysis.
    Lam F; Gill P; Smith M; Kitzmiller JL; Katz M
    Obstet Gynecol; 1988 Nov; 72(5):810-3. PubMed ID: 3173932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study.
    How HY; Zafaranchi L; Stella CL; Recht K; Maxwell RA; Sibai BM; Spinnato JA
    Am J Obstet Gynecol; 2006 Apr; 194(4):976-81. PubMed ID: 16580286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report.
    Levav AL; Chan L; Wapner RJ
    Am J Perinatol; 1998 Jan; 15(1):43-6. PubMed ID: 9475687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interval to spontaneous delivery following discontinuation of maintenance tocolysis.
    Jones JS; Morrison J; Istwan N; Rhea D; Collins A; Stanziano G
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):331-5. PubMed ID: 16801308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tocolysis of preterm contractions does not improve preterm delivery rate or perinatal outcomes.
    Sciscione AC; Stamilio DM; Manley JS; Shlossman PA; Gorman RT; Colmorgen GH
    Am J Perinatol; 1998 Mar; 15(3):177-81. PubMed ID: 9572373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of oral indomethacin and terbutaline sulfate for the long-term suppression of preterm labor.
    Bivins HA; Newman RB; Fyfe DA; Campbell BA; Stramm SL
    Am J Obstet Gynecol; 1993 Oct; 169(4):1065-70. PubMed ID: 8238121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy and economic outcomes in patients treated for recurrent preterm labor.
    Fleming A; Bonebrake R; Istwan N; Rhea D; Coleman S; Stanziano G
    J Perinatol; 2004 Apr; 24(4):223-7. PubMed ID: 14999214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks' gestation.
    Elliott JP; Istwan NB; Rhea DJ; Desch CN; Stanziano GJ
    Am J Perinatol; 2009 Feb; 26(2):123-8. PubMed ID: 18850519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral terbutaline after parenteral tocolysis.
    Lagace E
    J Fam Pract; 1997 Feb; 44(2):131-2. PubMed ID: 9040511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.